Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Shann

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Allergy|July 26, 2021
Prevention of infant eczema by neonatal Bacillus Calmette-Guérin vaccination: The MIS BAIR randomized controlled trialLaure F Pittet, Nicole L Messina, Kaya Gardiner, et al.
BMJ Open|December 18, 2019
Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality settingNicole L Messina, Kaya Gardiner, Susan Donath, et al.
The Journal of Infectious Diseases|June 19, 2021
Neonatal Bacille Calmette-Guérin Vaccination and Infections in the First Year of Life: The MIS BAIR Randomized Controlled TrialNicole L Messina, Laure F Pittet, Kaya Gardiner, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 14, 2024
Neonatal BCG Vaccination for Prevention of Allergy in Infants: The MIS BAIR Randomised Controlled TrialNicole L Messina, Kaya Gardiner, Laure F Pittet, et al.
Science Translational Medicine|May 8, 2020
BCG vaccination-induced emergency granulopoiesis provides rapid protection from neonatal sepsisByron Brook, Danny J Harbeson, Casey P Shannon, et al.
BMJ Open|October 29, 2021
BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial)Laure F Pittet, Nicole L Messina, Kaya Gardiner, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Allergy|July 26, 2021
Prevention of infant eczema by neonatal Bacillus Calmette-Guérin vaccination: The MIS BAIR randomized controlled trialLaure F Pittet, Nicole L Messina, Kaya Gardiner, et al.
BMJ Open|December 18, 2019
Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality settingNicole L Messina, Kaya Gardiner, Susan Donath, et al.
The Journal of Infectious Diseases|June 19, 2021
Neonatal Bacille Calmette-Guérin Vaccination and Infections in the First Year of Life: The MIS BAIR Randomized Controlled TrialNicole L Messina, Laure F Pittet, Kaya Gardiner, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 14, 2024
Neonatal BCG Vaccination for Prevention of Allergy in Infants: The MIS BAIR Randomised Controlled TrialNicole L Messina, Kaya Gardiner, Laure F Pittet, et al.
Science Translational Medicine|May 8, 2020
BCG vaccination-induced emergency granulopoiesis provides rapid protection from neonatal sepsisByron Brook, Danny J Harbeson, Casey P Shannon, et al.
BMJ Open|October 29, 2021
BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial)Laure F Pittet, Nicole L Messina, Kaya Gardiner, et al.
Pageof 5